Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

Gastroenterology

Targeted Solutions for Gastroenterology
April 18, 2024

Targeted Solutions for Gastroenterology

ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.

 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
April 18, 2024

Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring

In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..

Biomarker Monitoring for the Management of Crohn’s Disease
February 7, 2024

[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease

This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in conjunction with clinical symptoms. 

Calprotectin Test Differentiates IBD from IBS
October 23, 2023

Differentiating IBD from IBS with Fecal Calprotectin Testing

In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS. ALPCO tests enable clinicians to accurately assess patients via calprotectin and quickly start patients on the right treatment path.

AutoPlex Automated Multiplex Biomarker Analysis
September 25, 2023

AutoPlex Automated Multiplex Biomarker Analysis

ALPCO’s automated multiplex assay, AutoPlex GI Panel, provides sensitive and accurate measurement of up to 5 GI biomarkers in human stool samples. The panel combines the workflow advantages of multiplexing with the proven reliability of traditional chemiluminescence sandwich immunoassays to enable batched sample processing for related biomarkers. 

ALPCO's Superior Calprotectin Assay: Maximize Efficiency & Accuracy
September 22, 2023

ALPCO's Superior Calprotectin Assay: Maximize Efficiency & Accuracy

Reduce False Positives from 26% to 7%! An increase in clinical specificity, and a decrease in false positives, enables clinicians to better evaluate IBD/IBS patients. Clinicians can schedule follow-up colonoscopies for the patients that need it most and start IBS patients on the right treatment path.

Consolidate and Improve Calprotectin Testing on Clinical Chemistry Analyzers with ALPCO
September 22, 2023

Consolidate and Improve Calprotectin Testing on Clinical Chemistry Analyzers with ALPCO

For laboratories with a compatible clinical chemistry analyzer, upgrading to the calprotectin immunoturbidimetric assay can improve efficiency and generate additional capacity. Laboratories can potentially eliminate a CLIA system or simply create new capacity on that system by transferring calprotectin to another analyzer.

Boost Profitability with In-House Calprotectin Testing from ALPCO
September 22, 2023

Boost Profitability with In-House Calprotectin Testing from ALPCO

Test results from outside laboratories can sometimes take up to 5 days. Random access testing enables laboratories to offer affordable same-day results. On-site testing eliminates the shipping process and maintains remnant samples on-site.

High Throughput Calprotectin Testing with ALPCO Immunoturbidimetric Assay
September 22, 2023

High Throughput Calprotectin Testing with ALPCO Immunoturbidimetric Assay

Maximize lab efficiency with ALPCO's calprotectin immunoturbidimetric assay. Leverage existing analyzers, ensure accurate results, and improve turnaround times. 

Diagnostic Testing in GI Health
April 20, 2023

Diagnostic Testing in GI Health

 60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety and depression.2 The ongoing challenge relates to overlapping symptoms and the compl...